We can't seem to find what you're looking for. Please try a search.
post-acute sequelae of covid-19
Couldn't find anything
Notes
Bavarian Nordic sells Priority Review Voucher for 160 MUSD
Camurus CAM2029 shows efficacy in polycystic liver disease
Cantargia secures SEK 50 million in loan facility
Eli Lilly acquires Verve Therapeutics for $1,3 billion
Alzinova appoints Worldwide Clinical Trials as CRO
NEWSLETTER
NEWS
FDA introduces fast track for drugs of national importance
Positive outcome in phase I/IIa study for Oncoinvent
Alzinova is pursuing partnerships at BIO
Upcoming events!
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
Bispecific and Chinese the new black in cancer
The venture capital cycle is complete – we are back where we started
